Antiretroviral Therapy in the Malawi Defence Force: Access, Treatment Outcomes and Impact on Mortality
Author Information
Author(s): Banda Alfred C., Makombe Simon D., Jahn Andreas, Tweya Hannock, Chuka Stuart, Yu Joseph Kwong-Leung, Hedt Bethany, Weigel Ralf, Nkhata Amon, Schouten Erik J., Kamoto Kelita, Harries Anthony D.
Primary Institution: Malawi Defence Force, Medical Department, Lilongwe, Malawi
Hypothesis
How many army personnel accessed ART, their outcomes while on treatment, and whether ART impacted mortality rates in the Defence Force?
Conclusion
Army personnel had good access to ART with excellent treatment outcomes, leading to a significant reduction in mortality.
Supporting Evidence
- By December 31st 2006, 547 army personnel had accessed ART, with 67% alive and on ART at their registration facility.
- All-cause mortality in army personnel declined dramatically from 153 deaths in 2002 to 36 in 2006, a 76% reduction.
- 89.8% of army personnel were alive on ART at 6 months, 83.4% at 12 months, and 78.8% at 18 months.
Takeaway
This study shows that soldiers in Malawi are getting the medicine they need to fight HIV, and it's helping them live longer.
Methodology
A retrospective cohort analysis was conducted using data from ART clinics and army records to assess access, retention, and mortality.
Potential Biases
Potential undercounting of army personnel accessing ART due to discomfort in disclosing their occupation.
Limitations
Some patients may have underreported their occupation, and the average observation time was relatively short.
Participant Demographics
547 army personnel, predominantly male (96.2%), mean age 39 years.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website